Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019
Piperacillin sodium and tazobactam sodium is the compound drug of piperacillin sodium and tazobactam sodium, the former being semi-synthesized broad-spectrum penicillin while the latter being β-lactamase inhibitor. Tazobactam sodium can prevent piperacillin from the β-lactamase hydrolysis of some drug-resistant bacteria so as to maintain piperacillin’s antimicrobial activity or even expand its spectrum. The injection product of Piperacillin sodium and tazobactam sodium (piperacillin sodium and tazobactam sodium for injection) is often used in the clinic.
Since its first marketing in France in 1992, piperacillin sodium and tazobactam sodium has entered the US, mainland Europe, Japan and Singapore. According to CRI’s market survey, piperacillin sodium and tazobactam sodium develops fast after entering China in Oct. 1998, annual sales value rising from less than CNY 2 million in 2005 to CNY 1.064 billion in 2014 and CAGR during this period reaching 22.2%.
Wyeth Pharmaceutical Co., Ltd (US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United Laboratories occupy the majority of the Chinese market, among which Wyeth Pharmaceutical Co., Ltd (US) has the largest market share of about 36% for sales value in 2014.
Piperacillin sodium and tazobactam sodium has been widely applied in the clinic with efficacy being confirmed by the randomized controlled trials conducted by multiple centers at home and abroad. And it has been recommended by many domestic and foreign treatment guidelines as the first choice of the initial empirical therapy for hospital infection caused by unidentified pathogenic bacteria. The market size of piperacillin sodium and tazobactam sodium is expected to grow in China or in the whole world.
Readers can get at least the following information from this report:
market size of piperacillin sodium and tazobactam sodium in China
competitive landscape of piperacillin sodium and tazobactam sodium in Chinese market
price of piperacillin sodium and tazobactam sodium made by different enterprises in China
market outlook of piperacillin sodium and tazobactam sodium in China
The author suggests the following groups of people purchase this report:
manufacturers of anti-infectious drugs
investors/ research institutions interested in Chinese medicine market
any interest in the Chinese medicine market, please contact CRI for customized survey service
Please Note: All reports from China Research and Intelligence are written in Chinese, then translated to English. This process takes approximately 5 business days from the date the order is placed